References
- European Monitoring Centre for Drugs and Drug Addiction. New psychoactive substances in Europe. An update from the EU Early Warning System [Internet]; 2015 [cited 2016 May 5]. Available from: http://www.emcdda.europa.eu/system/files/publications/65/TD0415135ENN.pdf.
- Trecki J, Gerona RR, Schwartz MD. Synthetic cannabinoid related illnesses and deaths. N Engl J Med. 2015;373:103–107.
- Tait RJ, Caldicott D, Mountain D, et al. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol. 2016;54:1–13.
- Waugh J, Najafi J, Hawkins L, et al. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists. A report from the United Kingdom National Poison Information Service. Clin Toxicol (Phila). 2016; [Epub ahead of print]. DOI:10.3109/15563650.2016.1171329.
- Franz F, Schwörer N, Angerer V, et al. Metabolism and urine analysis of the new synthetic cannabinoid MDMB-CHMICA. Toxichem Krimtech. 2015;82:192–198.
- United National Office on Drugs and Crime (UNODC). Global smart update. Volume 13 [Internet]; 2015 [cited 2016 May 5]. Available from: https://www.unodc.org/documents/scientific/Global_SMART_Update_13_web.pdf.
- Police Scotland. Serious adverse events associated with MDMB-CHMICA in Europe [Internet]; 2016 [cited 2016 May 5]. Available from: http://www.lanarkshirehivandhepatitis.org/news-and-events/news/2016/02/09/police-scotland-serious-adverse-events-associated-with-mdmb-chmica-in-europe/.
- Westin Andreas AA, Frost J, Brede Wenche R, et al. Sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA. J Anal Toxicol. 2016;40:86–87.
- Adamowicz P. Fatal intoxication with synthetic cannabinoid MDMB-CHMICA. Forensic Sci Int. 2016;261:e5–e10.
- WEDINOS Working Group. Hospitalisation from synthetic cannabinoid MMB CHMINACA [Internet]; 2015 [cited 2016 May 5]. Available from: http://asfacarduf.org/wp-content/uploads/2015/07/MMB-CHMINACA-MDMB-CHMICA-alert.pdf.
- Pfitzer T, Niederhoffer N, Szabo B. Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats. Br J Pharmacol. 2004;142:943–952.
- Advisory Council on the Misuse of Drugs. ‘Third Generation’ synthetic cannabinoids [Internet]; 2014 [cited 2016 May 5]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/380161/CannabinoidsReport.pdf.
- National Archives. Psychoactive Substances Act 2016 [Internet]; 2016 [cited 2016 May 5]. Available from: http://www.legislation.gov.uk/ukpga/2016/2/pdfs/ukpga_20160002_en.pdf.